Payment is a benefit and why it matters for pediatric trials
Alan Wertheimer has argued persuasively that research ethics committees should be willing to count payment as a benefit when evaluating studies' risk–benefit ratios. In this paper, I begin by first recapitulating his argument and adding my own, complementary one. I then do two further things. F...
| Main Author: | |
|---|---|
| Format: | Electronic Article |
| Language: | English |
| Check availability: | HBZ Gateway |
| Journals Online & Print: | Drawer...
|
| Fernleihe: | Fernleihe für die Fachinformationsdienste |
| Published: |
Wiley-Blackwell
2022
|
| In: |
Bioethics
Year: 2022, Volume: 36, Issue: 7, Pages: 757-764 |
| IxTheo Classification: | NCH Medical ethics NCJ Ethics of science |
| Further subjects: | B
benefit analyses / risk
B research ethics B children and families |
| Online Access: |
Volltext (lizenzpflichtig) Volltext (lizenzpflichtig) |
MARC
| LEADER | 00000naa a22000002 4500 | ||
|---|---|---|---|
| 001 | 1814876715 | ||
| 003 | DE-627 | ||
| 005 | 20220820052556.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220820s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/bioe.13011 |2 doi | |
| 035 | |a (DE-627)1814876715 | ||
| 035 | |a (DE-599)KXP1814876715 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 1 |2 ssgn | ||
| 100 | 1 | |a Steel, Robert |e VerfasserIn |4 aut | |
| 245 | 1 | 0 | |a Payment is a benefit and why it matters for pediatric trials |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Alan Wertheimer has argued persuasively that research ethics committees should be willing to count payment as a benefit when evaluating studies' risk–benefit ratios. In this paper, I begin by first recapitulating his argument and adding my own, complementary one. I then do two further things. First, I explain why the practical implications of these arguments for studies enrolling competent adults are less than fully clear. Second, I explain why the practical implication for trials enrolling children are clear and significant. I argue that we should be comfortable paying children to compensate them for undergoing research risks. I propose we do so by putting money into accounts that the child gains access to upon attaining majority. | ||
| 650 | 4 | |a risk/benefit analyses | |
| 650 | 4 | |a research ethics | |
| 650 | 4 | |a children and families | |
| 652 | |a NCH:NCJ | ||
| 773 | 0 | 8 | |i Enthalten in |t Bioethics |d Oxford [u.a.] : Wiley-Blackwell, 1987 |g 36(2022), 7, Seite 757-764 |h Online-Ressource |w (DE-627)271596708 |w (DE-600)1480658-7 |w (DE-576)078707986 |x 1467-8519 |7 nnns |
| 773 | 1 | 8 | |g volume:36 |g year:2022 |g number:7 |g pages:757-764 |
| 856 | 4 | 0 | |u https://doi.org/10.1111/bioe.13011 |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/abs/10.1111/bioe.13011 |x Verlag |z lizenzpflichtig |3 Volltext |
| 935 | |a mteo | ||
| 936 | u | w | |d 36 |j 2022 |e 7 |h 757-764 |
| 951 | |a AR | ||
| ELC | |a 1 | ||
| ITA | |a 1 |t 1 | ||
| LOK | |0 000 xxxxxcx a22 zn 4500 | ||
| LOK | |0 001 4181432548 | ||
| LOK | |0 003 DE-627 | ||
| LOK | |0 004 1814876715 | ||
| LOK | |0 005 20220826143823 | ||
| LOK | |0 008 220820||||||||||||||||ger||||||| | ||
| LOK | |0 035 |a (DE-Tue135)IxTheo#2022-08-19#EBF6A3B9D85F8F4986C0F810818B5AA9A53AEA80 | ||
| LOK | |0 040 |a DE-Tue135 |c DE-627 |d DE-Tue135 | ||
| LOK | |0 092 |o n | ||
| LOK | |0 852 |a DE-Tue135 | ||
| LOK | |0 852 1 |9 00 | ||
| LOK | |0 935 |a ixzs |a zota | ||
| LOK | |0 936ln |0 1550736582 |a NCJ | ||
| LOK | |0 936ln |0 1550736558 |a NCH | ||
| ORI | |a SA-MARC-ixtheoa001.raw | ||